aTyr Pharma approves stock split proposal
- 59.04% of shares voted
- 52,451,734 votes for
- 5,234,645 votes against
ATYR
aTYR PHARMA INC SEC filings
Every EDGAR filing for aTYR PHARMA INC (ATYR), newest first, with AI summaries and stories.
- Ticker
- ATYR
- CIK
- 1339970
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE aTYR PHARMA INC reports 5.06% stake
- Federated Hermes, Inc. holds 4,965,414 shares
- 5.06% of class represented by shares
- Voting Shares Irrevocable Trust also involved
FEDERATED HERMES, INC., filed by
ROUTINE3aTYR PHARMA INCATYRLIVE 2 insider filings
Brandon Yaras, new insider at ATYR
Show all 2
- 3New insider at ATYR
- 4Insider filing for ATYR
Brandon Yaras
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINEDEF 14AaTYR PHARMA INCATYRLIVE ROUTINEPRE 14AaTYR PHARMA INCATYRLIVE ROUTINES-8aTYR PHARMA INCATYRLIVE NOTABLE10-QaTYR PHARMA INCATYRLIVE ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE Ownership stake disclosure by FEDERATED HERMES, INC. (amended)
FEDERATED HERMES, INC., filed by
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINE4aTYR PHARMA INCATYRLIVE Paul Schimmel, insider filing for ATYR
Paul Schimmel, reporting
NOTABLE10-QaTYR PHARMA INCATYRLIVE ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINE4aTYR PHARMA INCATYRLIVE 6 insider filings
Timothy Coughlin, insider filing for ATYR
Show all 6
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
Timothy Coughlin, reporting
ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINEARSaTYR PHARMA INCATYRLIVE ROUTINEDEFA14AaTYR PHARMA INCATYRLIVE ROUTINESCHEDULE 13G/AaTYR PHARMA INCATYRLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINEDEF 14AaTYR PHARMA INCATYRLIVE ROUTINEPRE 14AaTYR PHARMA INCATYRLIVE NOTABLE10-KaTYR PHARMA INCATYRLIVE ROUTINE8-KaTYR PHARMA INCATYRLIVE ROUTINE4aTYR PHARMA INCATYRLIVE 3 insider filings
Sanjay Shukla, insider filing for ATYR
Show all 3
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
Sanjay Shukla, reporting
ROUTINE4aTYR PHARMA INCATYRLIVE 3 insider filings
Sanjay Shukla, insider filing for ATYR
Show all 3
- 4Insider filing for ATYR
- 4Insider filing for ATYR
- 4Insider filing for ATYR
Sanjay Shukla, reporting
ROUTINE8-KaTYR PHARMA INCATYRLIVE NOTABLE10-QaTYR PHARMA INCATYRLIVE ROUTINE8-KaTYR PHARMA INCATYRLIVE